Status:
UNKNOWN
Exercise Capacity Before and After AF Ablation in Patients With HFpEF
Lead Sponsor:
University of Vermont
Conditions:
Heart Failure With Preserved Ejection Fraction
Atrial Fibrillation
Eligibility:
All Genders
18-110 years
Brief Summary
In a prospective, observational pilot study of patients scheduled for an atrial fibrillation (AF) ablation at the University of Vermont Medical Center the investigators will compare exercise capacity ...
Detailed Description
Patients ≥ 18 years of age who are scheduled for an AF ablation at the University of Vermont Medical Center will be screened for the following inclusion criteria: H2FpEF score of ≥ 6 (corresponding to...
Eligibility Criteria
Inclusion
- H2FpEF score of ≥ 6 (corresponding to \>90% probability of HFpEF (19))
- echocardiogram within the past 2 years that reported a LV ejection fraction ≥ 50%
- at least one symptom of HF (dyspnea on exertion, orthopnea or paroxysmal nocturnal dyspnea).
- AF ablation scheduled at UVMMC
Exclusion
- Life expectancy \<12 months
- moderate or more valvular disease
- inability to walk on a treadmill
Key Trial Info
Start Date :
April 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT05376748
Start Date
April 15 2022
End Date
December 30 2024
Last Update
June 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Vermont Medical Center
Burlington, Vermont, United States, 05405